Go to main content

Product Details

Raploc® is indicated for 

  • supraventricular tachycardia and for rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other circumstances where short-term control of the ventricular rate with a short acting agent is desirable.
  • for non-compensatory sinus tachycardia where, in the physician’s judgment the rapid heart rate requires specific intervention.
  • is not intended for use in chronic settings

Drug Facts

Active ingredient

Landiolol Hydrochloride